Islet cell failure in type 2 diabetes
Open accessThe DOI matches its Crossref record; 134 of the 134 references it cites were found in a registry or an index; none of the 272 sources its claims cite is checked for support yet.
Abstract
The major focus of this Review is on the mechanisms of islet beta cell failure in the pathogenesis of obesity-associated type 2 diabetes (T2D). As this demise occurs within the context of beta cell compensation for insulin resistance, consideration is also given to the mechanisms involved in the compensation process, including mechanisms for expansion of beta cell mass and for enhanced beta cell performance. The importance of genetic, intrauterine, and environmental factors in the determination of "susceptible" islets and overall risk for T2D is reviewed. The likely mechanisms of beta cell failure are discussed within the two broad categories: those with initiation and those with progression roles.
Overview
CoChat Summary
## TL;DR
This is a 2006 review arguing that type 2 diabetes develops when insulin-resistant islets can no longer sustain compensatory b cell function, leading first to dysfunction and then progressive loss of b cell mass. It emphasizes that “susceptible” islets are shaped by genetic, intrauterine, and environmental factors, and that hyperglycemia accelerates damage through glucotoxic and glucolipotoxic mechanisms.
## Key findings
- In longitudinal studies, insulin levels rise during the normoglycemic and prediabetes phases and then decline when fasting glycemia exceeds the upper normal limit of 5.5 mM, marking b cell failure.
- A longitudinal study in Pima Indians found that b cell dysfunction was the major determinant of progression from normoglycemia to diabetes.
- In autopsy pancreata from 124 subjects, the paper reports a 40% and 63% loss of islet b cell volume in obese subjects with impaired fasting glucose and T2D, respectively, compared with weight-matched controls; lean T2D subjects had a 41% loss versus lean controls.
- The paper reports that the STOP-NIDDM trial showed acarbose treatment of IGT subjects reduced the risk of progression to diabetes by 36%.
## Methods
- Narrative review of mechanistic, animal, human postmortem, genetic, and epidemiologic studies on islet b cell compensation and failure in obesity-associated T2D.
- Synthesizes findings from rodent models (including ZF, ZDF, DBA2, GK, and IUGR models) and human islet/pancreas studies, including a transcript profiling study of 7 normal and 5 T2D human islet samples.
- Main analysis is integrative and conceptual: it organizes evidence into mechanisms that promote compensation and mechanisms with initiation versus progression roles in b cell failure.
## Limitations
- The paper states that the mechanisms of b cell compensation are “not fully understood,” and that the role of several proposed factors remains to be established or warrants further investigation.
- It explicitly notes uncertainty about several mechanisms, including whether nonimmune islet inflammation contributes in vivo, whether IAPP is causal in b cell dysfunction and demise, and whether reduced ARNT expression is an early defect or a consequence.
- Evident from the text: this is a review, not a new experimental study, so its conclusions depend on the quality and consistency of the cited animal and human studies rather than on a single primary dataset.
Model-written summary. Check it against the paper before relying on it.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
0 Valid · 1 Not valid · 164 Not checked · 38 Own results and interpretations
In the paper
“Longitudinal studies of subjects that develop T2D show a rise in insulin levels in the normoglycemic and prediabetes phases that keep glycemia near normal despite the insulin resistance ( b cell compensation), followed by a decline when fasting glycemia surpasses the upper limit of normal of 5.5 mM ( b cell failure) (5) (Figure 1).”
What the sources say
- Not checked yetcites [5]
plainstates a cause- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: passes — The paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
In the paper
“With respect to the latter, increases were observed in enzymes and metabolites involved in anaplerosis and the malate-pyruvate and citratepyruvate shuttles of ZF islets (12).”
What the sources say
- Not checked yetcites [12]
plainstates a cause- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: passes — The paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
In the paper
“Inhibition of these pathways by phenylacetic acid, which inhibits PC, markedly impeded GSIS (12).”
What the sources say
- Not checked yetcites [12]
plainstates a cause- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: passes — The paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
None of the sources cited for this claim have been checked yet.
In the paper
“Studies of islet b cell compensation within models that maintain normoglycemia show upregulation of glucose metabolism pathways (12, 13, 31).”
What the sources say
- Not checked yetcites [12]
- Not checked yetcites [13]
- Not checked yetcites [31]
plainstates an association- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: passes — The paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
In the paper
“A recent study in Zucker fatty (ZF) rats has provided strong support for PKB activation in the b cell growth response to insulin resistance in this normoglycemic model (11).”
What the sources say
- Not checked yetcites [11]
boostedstates a cause- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: unclear — It is unclear whether the paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
116 more claims
Create a free account to see all 203 claims and to verify the 272 references still open.
- It may state two separate claims as one. 71
- Probably not a substantial claim. 13
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“Importantly, several of these studies have demonstrated that fatty acids do not induce beta-cell dysfunction in the absence of elevated glucose, highlighting that fatty acids and glucose are not cytotoxic independently.168,169”
From A review of current trends with type 2 diabetes epidemiology, aetiology, pathogenesis, treatments and future perspectives (2021) · cites this paper as [169]
Experimental — accuracy not yet measuredThe source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“Notably, impairment of insulin secretion in the presence of an intact β-cell mass also occurs in the early stages of human age-related diabetes123.”
From The telomere syndromes (2012) · cites this paper as [123]
Experimental — accuracy not yet measuredThe source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“Minor deficiencies in the β-cell machinery may only be exposed in times of metabolic stress, such as pregnancy [75].”
From The Pathophysiology of Gestational Diabetes Mellitus (2018) · cites this paper as [75]
Experimental — accuracy not yet measured
Citations
Cites
Mootha, V. K., Lindgren, C. M., Eriksson, K.-F., Subramanian, A., Sihag, S., Lehar, J., Puigserver, P., Carlsson, E., Ridderstråle, M., Laurila, E., et al. (2003) · Nature Genetics · doi:10.1038/ng1180 · Cited by 10,197
Global and societal implications of the diabetes epidemic
Zimmet, P., Alberti, K. G. M. M., & Shaw, J. (2001) · Nature · doi:10.1038/414782a · Cited by 5,883
β-Cell Deficit and Increased β-Cell Apoptosis in Humans With Type 2 Diabetes
Butler, A. E., Janson, J., Bonner-Weir, S., Ritzel, R., Rizza, R. A., & Butler, P. C. (2003) · Diabetes · doi:10.2337/diabetes.52.1.102 · Cited by 4,011
Acarbose for prevention of type 2 diabetes mellitus: the STOP-NIDDM randomised trial
Chiasson, J.-L., Josse, R. G., Gomis, R., Hanefeld, M., Karasik, A., & Laakso, M. (2002) · The Lancet · doi:10.1016/s0140-6736(02)08905-5 · Cited by 2,543
Barker, D. J. P., Hales, C. N., Fall, C. H. D., Osmond, C., Phipps, K., & Clark, P. M. S. (1993) · Diabetologia · doi:10.1007/bf00399095 · Cited by 2,468
Variant of transcription factor 7-like 2 (TCF7L2) gene confers risk of type 2 diabetes
Grant, S. F. A., Thorleifsson, G., Reynisdottir, I., Benediktsson, R., Manolescu, A., Sainz, J., Helgason, A., Stefansson, H., Emilsson, V., Helgadottir, A., et al. (2006) · Nature Genetics · doi:10.1038/ng1732 · Cited by 2,287
The biology of incretin hormones
Drucker, D. J. (2006) · Cell Metabolism · doi:10.1016/j.cmet.2006.01.004 · Cited by 2,210
Mitochondrial dysfunction and type 2 diabetes
Lowell, B. B., & Shulman, G. I. (2005) · Science · doi:10.1126/science.1104343 · Cited by 2,070
Leptin stimulates fatty-acid oxidation by activating AMP-activated protein kinase
Minokoshi, Y., Kim, Y.-B., Peroni, O. D., Fryer, L. G. D., Müller, C., Carling, D., & Kahn, B. B. (2002) · Nature · doi:10.1038/415339a · Cited by 2,053
Weyer, C., Bogardus, C., Mott, D. M., & Pratley, R. E. (1999) · Journal of Clinical Investigation · doi:10.1172/jci7231 · Cited by 1,940
Cited by
Items 501–600 of 1,002
Isolation and characterization of islet stellate cells in rat
Zha, M., Li, F.-F., Xu, W. G., Chen, B., & Sun, Z. (2014) · Islets · doi:10.4161/isl.28701 · Cited by 50
Cole, B. K., Morris, M. A., Grzesik, W. J., Leone, K. A., & Nadler, J. L. (2012) · Mediators of Inflammation · doi:10.1155/2012/851798 · Cited by 53
Lauria, A., Barker, A., Schloot, N., Hosszufalusi, N., Ludvigsson, J., Mathieu, C., Mauricio, D., Nordwall, M., Van der Schueren, B., Mandrup-Poulsen, T., et al. (2015) · European Journal of Endocrinology · doi:10.1530/eje-14-0522 · Cited by 49
14-3-3 proteins are essential signalling hubs for beta cell survival
Lim, G. E., Piske, M., & Johnson, J. D. (2013) · Diabetologia · doi:10.1007/s00125-012-2820-x · Cited by 47
Lee, H., Choi, J., Shin, S. S., & Yoon, M. (2015) · Journal of Ethnopharmacology · doi:10.1016/j.jep.2015.12.017 · Cited by 51
“In insulin-resistant states, pancreatic islet β cells usually respond by increasing insulin secretion to maintain normal blood glucose levels (Prentki and Nolan, 2006).”
BackgroundZhao, H., Matsuzaka, T., Nakano, Y., Motomura, K., Tang, N., Yokoo, T., Okajima, Y., Han, S., Takeuchi, Y., Aita, Y., et al. (2017) · Diabetes · doi:10.2337/db16-1277 · Cited by 57
“b-Cells respond to endogenous stimuli, including FAs, by initiating macrophage recruitment via production of chemokines, and subsequent interactions between b-cells and macrophages perpetuate inflammatory processes within islets that lead to b-cell dysfunction (3,39,40).”
BackgroundSharma, A., Mah, M., Ritchie, R. H., & Blasio, M. J. D. (2021) · Pharmacology & Therapeutics · doi:10.1016/j.pharmthera.2021.108008 · Cited by 53
Use of anti-diabetic drugs and glycaemic control in type 2 diabetes—The Hong Kong Diabetes Registry
Tong, P. C. Y., Ko, G. T. C., So, W., Chiang, S.-C., Yang, X., Kong, A. P. S., Ozaki, R., Ronald, C. W., Cockram, C. S., Chow, C., et al. (2008) · Diabetes Research and Clinical Practice · doi:10.1016/j.diabres.2008.09.006 · Cited by 58
Hudson, B. D., Smith, N. J., & Milligan, G. (2011) · Advances in pharmacology · doi:10.1016/b978-0-12-385952-5.00006-3 · Cited by 53
Malin, S. K., Kirwan, J. P., Sia, C. L., & González, F. (2015) · American Journal of Physiology-Endocrinology and Metabolism · doi:10.1152/ajpendo.00510.2014 · Cited by 49
Fernandes, J., Vogt, J. A., & Wolever, T. M. S. (2011) · European Journal of Clinical Nutrition · doi:10.1038/ejcn.2011.116 · Cited by 58
Śliwińska, A., Rogalska, A., Szwed, M., Kasznicki, J., Jóźwiak, Z., & Drzewoski, J. (2011) · Molecular Biology Reports · doi:10.1007/s11033-011-1323-z · Cited by 53
Hatanaka, M., Maier, B., Sims, E. K., Templin, A. T., Kulkarni, R., Evans‐Molina, C., & Mirmira, R. G. (2014) · Diabetes · doi:10.2337/db14-0105 · Cited by 57
“Failure to maintain the necessary state of augmented β cell mass and/or function leads to the development of type 2 diabetes (T2D) (1,2).”
Delghingaro-Augusto, V., Décary, S., Peyot, M.-L., Latour, M. G., Lamontagne, J., Paradis-Isler, N., Lacharité-Lemieux, M., Akakpo, H., Birot, O., Nolan, C. J., et al. (2012) · American Journal of Physiology-Endocrinology and Metabolism · doi:10.1152/ajpendo.00360.2011 · Cited by 49
Self-citationDecreasing CB1 receptor signaling in Kupffer cells improves insulin sensitivity in obese mice
Jourdan, T., Nicoloro, S. M. C., Zhou, Z., Shen, Y., Liu, J., Coffey, N. J., Çınar, R., Godlewski, G., Gao, B., Aouadi, M., et al. (2017) · Molecular Metabolism · doi:10.1016/j.molmet.2017.08.011 · Cited by 53
Traish, A. M. (2017) · Advances in experimental medicine and biology · doi:10.1007/978-3-319-70178-3_22 · Cited by 58
Optical tools for understanding the complexity of β-cell signalling and insulin release
Frank, J. A., Broichhagen, J., Yushchenko, D. A., Trauner, D. H., Schultz, C., & Hodson, D. J. (2018) · Nature Reviews Endocrinology · doi:10.1038/s41574-018-0105-2 · Cited by 48
The obesity paradox and diabetes
Gravina, G., Ferrari, F., & Nebbiai, G. (2020) · Eating and Weight Disorders - Studies on Anorexia Bulimia and Obesity · doi:10.1007/s40519-020-01015-1 · Cited by 56
Phytochemicals as Potential Epidrugs in Type 2 Diabetes Mellitus
Ramírez‐Alarcón, K., Victoriano, M., Mardones, L., Villagrán, M., Al‐Harrasi, A., Al-Rawahi, A. N., Martins, N. A., Sharifi‐Rad, J., & Martorell, M. (2021) · Frontiers in Endocrinology · doi:10.3389/fendo.2021.656978 · Cited by 55
“org 3 alterations occur and mediate islet dysfunction before the onset of diabetes (36).”
BackgroundLiu, H., Cao, M.-M., Wang, Y., Li, L.-C., Zhu, L., Xie, G., & Li, Y. (2014) · General and Comparative Endocrinology · doi:10.1016/j.ygcen.2014.09.006 · Cited by 49
García-Hernández, M. H., Portales‐Cervantes, L., Cortez-Espinosa, N., Morales, J. M. V., Fritche‐Salazar, J. F., Rivera-López, E., Rodríguez-Rivera, J., Quezada‐Calvillo, R., & Portales‐Pérez, D. P. (2011) · Cellular Immunology · doi:10.1016/j.cellimm.2011.03.022 · Cited by 54
G6PD Up-Regulation Promotes Pancreatic β-Cell Dysfunction
Lee, J.-W., Choi, A. H., Ham, M., Kim, J.-W., Choe, S. S., Park, J., Lee, G. Y., Yoon, K., & Kim, J. B. (2011) · Endocrinology · doi:10.1210/en.2010-0606 · Cited by 55
Adipose differentiation-related protein regulates lipids and insulin in pancreatic islets
Faleck, D. M., Ali, K., Roat, R., Graham, M. J., Crooke, R. M., Battisti, R., Garcia, E., Ahima, R. S., & Imai, Y. (2010) · American Journal of Physiology-Endocrinology and Metabolism · doi:10.1152/ajpendo.00646.2009 · Cited by 49
Narváez, J. J. U., & Campos, M. R. S. (2021) · Journal of Food Science · doi:10.1111/1750-3841.15939 · Cited by 65
ER stress in adipocytes and insulin resistance: Mechanisms and significance (Review)
Khan, S. M., & WANG, C. H. (2014) · Molecular Medicine Reports · doi:10.3892/mmr.2014.2532 · Cited by 51
The Role of Peroxidation of Mitochondrial Membrane Phospholipids in Pancreatic β -Cell Failure
Ma, Z. A. (2011) · Current Diabetes Reviews · doi:10.2174/157339912798829232 · Cited by 53
Reynolds, M. S., Hancock, C. R., Ray, J. D., Kener, K. B., Draney, C., Garland, K., Hardman, J. M., Bikman, B. T., & Tessem, J. S. (2016) · American Journal of Physiology-Endocrinology and Metabolism · doi:10.1152/ajpendo.00022.2016 · Cited by 58
Loss of Free Fatty Acid Receptor 2 leads to impaired islet mass and beta cell survival
Villa, S. R., Priyadarshini, M., Fuller, M. H., Bhardwaj, T., Brodsky, M. R., Angueira, A. R., Mosser, R. E., Carboneau, L., Tersey, S. A., Mancebo, H. S. Y., et al. (2016) · Scientific Reports · doi:10.1038/srep28159 · Cited by 49
Possik, E., Madiraju, S. R. M., & Prentki, M. (2017) · Biochimie · doi:10.1016/j.biochi.2017.08.001 · Cited by 50
Self-citationNavik, U., Sheth, V. G., Kabeer, S. W., & Tikoo, K. (2019) · Molecular Nutrition & Food Research · doi:10.1002/mnfr.201801401 · Cited by 47
Yang, Y., Zhao, C., Ye, Y., Yu, M., & Qu, X. (2020) · Frontiers in Endocrinology · doi:10.3389/fendo.2020.00190 · Cited by 54
Skovsø, S., Panzhinskiy, E., Kolic, J., Cen, H. H., Dionne, D. A., Dai, X.-Q., Sharma, R. B., Elghazi, L., Ellis, C. E., Faulkner, K., et al. (2022) · Nature Communications · doi:10.1038/s41467-022-28039-8 · Cited by 50
“To set the parameter values in our model for this exploration, we started with the Topp model, originally parametrized for humans and gradually varied them with two simultaneous objectives: (1) ensure that a simulated glucose tolerance test roughly matched a typical wildtype female low-fat diet glucose tolerance test…”
Beeler, N., Riederer, B. M., Waeber, G., & Abderrahmani, A. (2009) · Brain Research Bulletin · doi:10.1016/j.brainresbull.2009.07.006 · Cited by 53
Metabolic reprogramming in type 2 diabetes and the development of breast cancer
Martin, S. D., & McGee, S. L. (2018) · Journal of Endocrinology · doi:10.1530/joe-18-0037 · Cited by 49
Thouvenot, K., Turpin, T., Taïlé, J., Clément, K., Meilhac, O., & Gonthier, M. (2022) · Biomolecules · doi:10.3390/biom12030378 · Cited by 59
“As a result of this insulin resistance, the pancreas first enters into a “compensatory period” in which β-cells hypertrophy and produce more insulin [25].”
BackgroundGlucose regulation of β ‐cell stress in type 2 diabetes
Leibowitz, G., Bachar-Wikström, E., Shaked, M., Sinai, A., Ketzinel‐Gilad, M., Cerasi, E., & Kaiser, Ν. (2010) · Diabetes Obesity and Metabolism · doi:10.1111/j.1463-1326.2010.01280.x · Cited by 51
Karunakaran, U., Kim, H., Kim, J.-Y., & Lee, I. (2011) · Experimental Diabetes Research · doi:10.1155/2012/639762 · Cited by 53
Babu, D. A., Chakrabarti, S. K., Garmey, J. C., & Mirmira, R. G. (2008) · Journal of Biological Chemistry · doi:10.1074/jbc.m800336200 · Cited by 50
Ye, R., Ni, M., Wang, M., Luo, S. D., Zhu, G., Chow, R. H.-P., & Lee, A. S. (2011) · Journal of Endocrinology · doi:10.1530/joe-11-0012 · Cited by 48
Lee, H., Im, S. W., Jung, C. H., Jang, Y. J., Ha, T. Y., & Ahn, J. (2015) · Biochemical and Biophysical Research Communications · doi:10.1016/j.bbrc.2015.12.036 · Cited by 52
Remote control of glucose homeostasis in vivo using photopharmacology
Mehta, Z. B., Johnston, N. R., Nguyen‐Tu, M., Broichhagen, J., Schultz, P., Larner, D. P., Leclerc, I., Trauner, D. H., Rutter, G. A., & Hodson, D. J. (2017) · Scientific Reports · doi:10.1038/s41598-017-00397-0 · Cited by 49
Wang, Q., Zheng, Y., Zhuang, W., Lu, X., Luo, X., & Zheng, B. (2018) · Food Chemistry · doi:10.1016/j.foodchem.2018.05.056 · Cited by 53
Ma, J., Meng, X., Liu, Y., Cheng, Y., Zhang, T., Wang, P., Park, Y., & Jung, H. W. (2020) · Journal of Ethnopharmacology · doi:10.1016/j.jep.2020.112926 · Cited by 50
Frigerio, F., Brun, T., Bartley, C., Usardi, A., Bosco, D., Ravnskjær, K., Mandrup, S., & Maechler, P. (2009) · Diabetologia · doi:10.1007/s00125-009-1590-6 · Cited by 49
Natalicchio, A., Tortosa, F., Labarbuta, R., Biondi, G., Marrano, N., Carchia, E., Leonardini, A., Cignarelli, A., Bugliani, M., Marchetti, P., et al. (2015) · Diabetologia · doi:10.1007/s00125-015-3563-2 · Cited by 49
Åkerfeldt, M. C., & Laybutt, D. R. (2011) · Diabetes · doi:10.2337/db11-0083 · Cited by 50
Tonne, J. M., Sakuma, T., Deeds, M. C., Munoz-Gomez, M., Barry, M. A., Kudva, Y. C., & Ikeda, Y. (2013) · Disease Models & Mechanisms · doi:10.1242/dmm.012591 · Cited by 48
“In human type 2 diabetes, glucolipotoxicity, ER stress and oxidative stress have been implicated in the progressive β-cell failure (Prentki and Nolan, 2006).”
BackgroundTahara, A., Takasu, T., Yokono, M., Imamura, M., & Kurosaki, E. (2016) · Journal of Pharmacological Sciences · doi:10.1016/j.jphs.2016.06.004 · Cited by 46
Bartley, C., Brun, T., Oberhauser, L., Grimaldi, M., Molica, F., Kwak, B. R., Bosco, D., Chanson, M., & Maechler, P. (2019) · American Journal of Physiology-Endocrinology and Metabolism · doi:10.1152/ajpendo.00456.2018 · Cited by 48
Szunerits, S., Melinte, S., Barras, A., Pagneux, Q., Voronova, A., Abderrahmani, A., & Boukherroub, R. (2021) · Chemical Society Reviews · doi:10.1039/c9cs00886a · Cited by 49
Robbins, R. D., Tersey, S. A., Ogihara, T., Gupta, D., Farb, T. B., FICORILLI, J. V., Bokvist, K. B., Maier, B., & Mirmira, R. G. (2010) · Journal of Biological Chemistry · doi:10.1074/jbc.m110.170142 · Cited by 48
The long non-coding RNA βFaar regulates islet β-cell function and survival during obesity in mice
Zhang, F., Yang, Y., Chen, X., Liu, Y., Hu, Q., Huang, B., Liu, Y., Pan, Y., Zhang, Y., Liu, D., et al. (2021) · Nature Communications · doi:10.1038/s41467-021-24302-6 · Cited by 47
Xu, T., Yu, Z. H., Liu, Y., Lu, M., Gong, M., Li, Q., Xia, Y., & Xu, B. (2021) · Molecular Neurobiology · doi:10.1007/s12035-021-02609-1 · Cited by 50
“Pancreatic β cell dysfunction is central to the pathogenesis of type 2 diabetes [7].”
BackgroundSGLT2 inhibitors: a promising new therapeutic option for treatment of type 2 diabetes mellitus
Misra, M. (2012) · Journal of Pharmacy and Pharmacology · doi:10.1111/j.2042-7158.2012.01574.x · Cited by 45
Pistrosch, F., Köhler, C. U., Schäper, F., Landgraf, W., Forst, T. M., & Hanefeld, M. (2013) · Acta Diabetologica · doi:10.1007/s00592-012-0451-9 · Cited by 48
Park, Y. J., Ao, Z., Kieffer, T. J., Chen, H., Safikhan, N., Thompson, D. M., Meloche, M. R., Warnock, G. L., & Marzban, L. (2012) · Diabetologia · doi:10.1007/s00125-012-2802-z · Cited by 50
“Type 2 diabetes is characterised by progressive beta cell failure and reduced beta cell mass [1, 2] associated with islet amyloid formation [3–5].”
BackgroundCould microRNAs contribute to the maintenance of β cell identity?
Kaspi, H., Pasvolsky, R., & Hornstein, E. (2014) · Trends in Endocrinology and Metabolism · doi:10.1016/j.tem.2014.01.003 · Cited by 45
Allagnat, F., Alonso, F., Martin, D., Abderrahmani, A., Waeber, G., & Haefliger, J.-A. (2008) · Journal of Biological Chemistry · doi:10.1074/jbc.m708181200 · Cited by 44
Jaworski, D. M., Sideleva, O., Stradecki, H. M., Langlois, G. D., Habibovic, A., Satish, B., Tharp, W. G., Lausier, J., LaRock, K., Jetton, T. L., et al. (2011) · Endocrinology · doi:10.1210/en.2010-1029 · Cited by 45
Autophagy in health and disease. 4. The role of pancreatic β-cell autophagy in health and diabetes
Fujitani, Y., Ueno, T., & Watada, H. (2010) · American Journal of Physiology-Cell Physiology · doi:10.1152/ajpcell.00084.2010 · Cited by 48
Developmental Role of Macrophage Cannabinoid-1 Receptor Signaling in Type 2 Diabetes
Jourdan, T., Szanda, G., Çınar, R., Godlewski, G., Holovac, D. J., Park, J. K., Nicoloro, S. M. C., Shen, Y., Liu, J., Rosenberg, A. Z., et al. (2017) · Diabetes · doi:10.2337/db16-1199 · Cited by 50
mTORC2 Signaling: A Path for Pancreatic β Cell's Growth and Function
Yuan, T., Lupše, B., Maedler, K., & Ardestani, A. D. (2018) · Journal of Molecular Biology · doi:10.1016/j.jmb.2018.02.013 · Cited by 51
Zhang, F. F., Liu, Y. H., Wang, D. W., Liu, T. S., Yang, Y., Guo, J., Pan, Y., Zhang, Y. F., Du, H., Li, L., et al. (2020) · Diabetologia · doi:10.1007/s00125-020-05090-y · Cited by 48
ATP-dependent potassium channels and type 2 diabetes mellitus
Bonfanti, D. H., Alcazar, L. P., Arakaki, P. A., Martins, L. T., Agustini, B. C., Rego, F. G. D. M., & Frigeri, H. R. (2015) · Clinical Biochemistry · doi:10.1016/j.clinbiochem.2014.12.026 · Cited by 47
Endoplasmic Reticulum Stress and Its Impact on Adipogenesis: Molecular Mechanisms Implicated
Kim, G., Lee, J., Ha, J., Kang, I., & Choe, W. (2023) · Nutrients · doi:10.3390/nu15245082 · Cited by 49
“Pancreatic islet β cells are specialized secretory cells responsible for insulin storage, and they produce more insulin in insulin-resistant states [97,98].”
BackgroundAdaptive changes of human islets to an obesogenic environment in the mouse
Gargani, S., Thévenet, J., Yuan, J. E., Lefebvre, B., Delalleau, N., Gmyr, V., Hubert, T., Duhamel, A., Pattou, F., & Kerr-Conte, J. (2013) · Diabetologia · doi:10.1007/s00125-012-2775-y · Cited by 44
Ultrastructural morphometric analysis of insulin secretory granules in human type 2 diabetes
Masini, M., Marselli, L., Bugliani, M., Martino, L., Masiello, P., Marchetti, P., & Tata, V. D. (2012) · Acta Diabetologica · doi:10.1007/s00592-012-0446-6 · Cited by 46
Briand, O., Helleboid‐Chapman, A., Ploton, M., Hennuyer, N., Carpentier, R., Pattou, F. N., Vandewalle, B., Moerman, E., Gmyr, V., Kerr-Conte, J. A., et al. (2012) · Molecular Endocrinology · doi:10.1210/me.2011-1317 · Cited by 47
Alemany, M. (2012) · Frontiers in Endocrinology · doi:10.3389/fendo.2012.00027 · Cited by 48
Nifedipine Protects INS-1 β-Cell from High Glucose-Induced ER Stress and Apoptosis
Wang, Y., Gao, L., Li, Y., Chen, H., & Sun, Z. (2011) · International Journal of Molecular Sciences · doi:10.3390/ijms12117569 · Cited by 47
Do, O. H., Gunton, J. E., Gaisano, H. Y., & Thorn, P. (2016) · Diabetologia · doi:10.1007/s00125-016-3942-3 · Cited by 51
“A key feature of the later disease stages is the failure of insulin secretion from beta cells to meet the demand of increased peripheral insulin resistance [1, 5].”
BackgroundLi, J., Wu, N., Cheng, X. J., Chen, H., Yang, X., & Liu, C. (2019) · Islets · doi:10.1080/19382014.2019.1690944 · Cited by 48
Impact of Pregnancy and Lactation on the Long-Term Regulation of Energy Balance in Female Mice
Ladyman, S. R., Aung, Z. K., & Grattan, D. R. (2018) · Endocrinology · doi:10.1210/en.2018-00057 · Cited by 52
Sun, P. G., Wang, T., Zhou, Y., Liu, H., Jiang, H., Zhu, W., & Wang, H. (2013) · PLoS ONE · doi:10.1371/journal.pone.0066744 · Cited by 47
“Finally, constant increased secretion of insulin leads to b-cell exhaustion [21,22].”
BackgroundBarbarroja, N., López-Pedrera, C., Garrido‐Sánchez, L., Mayas, M. D., Oliva‐Olivera, W., Bernal-López, M. R., Bekay, R. E., & Tinahones, F. J. (2012) · PLoS ONE · doi:10.1371/journal.pone.0048155 · Cited by 46
de Oliveira, R. B., Maschio, D. A., Carvalho, C. P. D. F., & Collares‐Buzato, C. B. (2015) · Annals of Anatomy - Anatomischer Anzeiger · doi:10.1016/j.aanat.2015.01.007 · Cited by 47
Velásquez, C., Velásquez-Villa, M., Ocampo, L. G., & Bermúdez-Cardona, J. (2014) · BMC Pediatrics · doi:10.1186/1471-2431-14-258 · Cited by 51
Shridas, P., Zahoor, L., Forrest, K. J., Layne, J. D., & Webb, N. R. (2014) · Journal of Biological Chemistry · doi:10.1074/jbc.m114.591735 · Cited by 42
Islet Autotransplantation and Total Pancreatectomy
Witkowski, P., Savari, O., & Matthews, J. B. (2014) · Advances in Surgery · doi:10.1016/j.yasu.2014.05.006 · Cited by 43
Mechanisms of Protective Effects of SGLT2 Inhibitors in Cardiovascular Disease and Renal Dysfunction
Liu, B., Wang, Y., Zhang, Y., & Yan, B. (2019) · Current Topics in Medicinal Chemistry · doi:10.2174/1568026619666190828161409 · Cited by 45
Antidiabetic Activity of Gold Nanoparticles Synthesized Using Wedelolactone in RIN-5F Cell Line
Vinayagam, R., Mariadoss, A. V. A., David, E. K., Venkatachalam, K., Vijayakumar, S., Sankaran, V., Balupillai, A., Sangeetha, C. C., Muthukaliannan, G. K., Kotakadi, V. S., et al. (2019) · Antioxidants · doi:10.3390/antiox9010008 · Cited by 42
Weiss, E. P., Brandauer, J., Kulaputana, O., Ghiu, I. A., Wohn, C. R., Phares, D. A., Shuldiner, A. R., & Hagberg, J. M. (2007) · American Journal of Clinical Nutrition · doi:10.1093/ajcn/85.1.102 · Cited by 44
Ko, S., Ryu, G. R., Kim, S., Ahn, Y., Yoon, K., Kaneto, H., Ha, H., Kim, Y. S., & Song, K. (2008) · Transplantation · doi:10.1097/tp.0b013e31816168f9 · Cited by 42
Drivers for the comorbidity of type 2 diabetes mellitus and epilepsy: A scoping review
Shlobin, N. A., & Sander, J. W. A. S. (2020) · Epilepsy & Behavior · doi:10.1016/j.yebeh.2020.107043 · Cited by 42
“Pancreatic islet β-cells compensate for insulin resistance by hypersecreting insulin to maintain normoglycemia [33].”
BackgroundXu, W., Qadir, M. M. F., Nasteska, D., de Sa, P. M., Gorvin, C. M., Blandino-Rosano, M., Evans, C. R., Ho, T., Potapenko, E. S., Veluthakal, R., et al. (2023) · Cell Reports · doi:10.1016/j.celrep.2023.112529 · Cited by 45
Evaluation of circulating betatrophin levels in gestational diabetes mellitus
Erol, O. Ö., Ellidağ, H. Y., Ayık, H., Özel, M. K., Derbent, A. U., & Yılmaz, N. (2015) · Gynecological Endocrinology · doi:10.3109/09513590.2015.1056142 · Cited by 43
“Pregnancy-induced insulin resistance is considered as a pancreatic beta-cell stress test for the prediction of type 2 DM risk [4].”
BackgroundSoty, M., Visa, M., Soriano, S., Carmona, M. C., Nadal, Á., & Novials, A. (2011) · Journal of Biological Chemistry · doi:10.1074/jbc.m111.232801 · Cited by 44
Zhang, Z., Li, J., Yang, L., Chen, R., Yang, R., Zhang, H., Cai, D.-H., & Chen, H. (2014) · Journal of Diabetes Research · doi:10.1155/2014/712781 · Cited by 51
Barbero-Fernández, A., Astiz, S., López-Bote, C. J., Pérez-Solana, M. L., Ayuso, M., Real, I. G., & Gonzalez‐Bulnes, A. (2013) · PLoS ONE · doi:10.1371/journal.pone.0078424 · Cited by 42
Mechanistic insights into pancreatic beta-cell mass regulation by glucose and free fatty acids
Oh, Y. S. (2015) · Anatomy & Cell Biology · doi:10.5115/acb.2015.48.1.16 · Cited by 49
García-Aguilar, A., Guillén, C., Nellist, M. D., Bartolomé, A., & Benito, M. (2016) · Biochimica et Biophysica Acta (BBA) - Molecular Cell Research · doi:10.1016/j.bbamcr.2016.08.006 · Cited by 44
AMPK and Friends: Central Regulators of β Cell Biology
Rourke, J. L., Hu, Q., & Screaton, R. A. (2017) · Trends in Endocrinology and Metabolism · doi:10.1016/j.tem.2017.11.007 · Cited by 46
Bellini, L., Campaña, M. B., Rouch, C., Chacińska, M., Bugliani, M., Meneyrol, K., Hainault, I., Lenoir, V., Denom, J., Véret, J., et al. (2018) · Diabetologia · doi:10.1007/s00125-018-4629-8 · Cited by 39
Zhang, Y., He, Z., Liu, X., Chen, Z., Sun, J., Wu, Z., Yang, X., Chen, X., Tang, Z., & Wang, K. (2019) · Journal of Functional Foods · doi:10.1016/j.jff.2019.01.037 · Cited by 44
β-Cell Death in Diabetes: Past Discoveries, Present Understanding, and Potential Future Advances
Mukherjee, N., Lin, L., Contreras, C., & Templin, A. T. (2021) · Metabolites · doi:10.3390/metabo11110796 · Cited by 49
Lipid Droplets’ Role in the Regulation of β-Cell Function and β-Cell Demise in Type 2 Diabetes
Tong, X., Liu, S., Stein, R. W., & Imai, Y. (2022) · Endocrinology · doi:10.1210/endocr/bqac007 · Cited by 44
Neutral sphingomyelinase‐2 and cardiometabolic diseases
Sindhu, S. T. A. K., Leung, Y. H., Arefanian, H., Madiraju, S. R. M., Al‐Mulla, F., Ahmad, R., & Prentki, M. (2021) · Obesity Reviews · doi:10.1111/obr.13248 · Cited by 48
“cation of fatty acyl-CoA and accumulation of diacylglycerols and ceramides.(144,145) In the β-cell, even though ceramide synthesis is thought to be predominantly via the de novo pathway, starting from serine and palmitoyl-CoA,(146) nSMase2 has also been shown to contribute to ceramide synthesis under conditions of ER…”
BackgroundSelf-citationFernández‐Costa, J. M., Ortega, M. A., Rodríguez‐Comas, J., López‐Muñoz, G. A., Yeste, J., Mangas‐Florencio, L., Fernandez‐González, M., Martin‐Lasierra, E., Tejedera‐Villafranca, A., & Ramón‐Azcón, J. (2022) · Advanced Materials Technologies · doi:10.1002/admt.202200873 · Cited by 48
Ghrelin inhibits cell apoptosis induced by lipotoxicity in pancreatic β-cell line
Wang, W., Zhang, D., Zhao, H., Chen, Y., Liu, Y., Cao, C.-P., Han, L., & Liu, G. (2010) · Regulatory Peptides · doi:10.1016/j.regpep.2009.12.017 · Cited by 42
Functional implications of long non-coding RNAs in the pancreatic islets of Langerhans
Esguerra, J. L. S., & Eliasson, L. (2014) · Frontiers in Genetics · doi:10.3389/fgene.2014.00209 · Cited by 41
Metadata
- Authors
- Prentki, M.
- Affiliations
- Centre Hospitalier de l’Université de Montréal (CA)
- Corresponding author
- Prentki, M.
- ORCID
- Prentki, M.
- Venue
- Journal of Clinical Investigation
- Published
- 2006-07-03
- Volume
- 116
- Issue
- 7
- Pages
- 1802-1812
- ISSN
- 0021-9738 (ISSN-L)
- PMC
- PMC1483155
- OpenAlex
- W1598254642
- Cited by
- 1,690
- References
- 132
- Citations by year
- 2026: 52 · 2025: 52 · 2024: 46 · 2023: 54 · 2022: 68 · 2021: 95 · 2020: 95 · 2019: 111 · 2018: 90 · 2017: 109 · 2016: 112 · 2015: 107 · 2014: 131 · 2013: 97 · 2012: 98
- FWCI
- 13.11
- Type
- journal article
- Language
- en
- Open access
- bronze
- doi.org
- Locations
- Journal of Clinical Investigation (publishedVersion)
- Europe PMC (PubMed Central) (publishedVersion)
- PubMed Central (publishedVersion)
- PubMed (publishedVersion)
- ANU Open Research (Australian National University) (submittedVersion)
- Funders
- ACT Government
- National Institutes of Health
- National Institute of Diabetes and Digestive and Kidney Diseases (R01DK063356, DK63356)
- Topics
- Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Pancreatic function and diabetes
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Genetics › Diabetes and associated disorders
- Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Diabetes Treatment and Management
- Keywords
- beta-cell failure, type 2 diabetes, obesity, beta-cell compensation, beta-cell mass expansion, insulin resistance, genetic susceptibility, intrauterine factors, environmental risk factors, beta-cell dysfunction
- MeSH terms
- Animals, Diabetes Mellitus, Type 2, Humans, Insulin Resistance, Disease Progression, Genetic Predisposition to Disease, Insulin-Secreting Cells
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
A language model drew the claims from the paper on 2026-10-11, under version 3 of the claim definition (model deepseek-v4.1-flash, prompt extract-v3).
A second model labelled each claim on 2026-10-11 (model jev-1.13-20260917, definition revision gold-guideline-v0.2).
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.